Teams link: Join the Meeting Now

Meeting ID: 234 297 242 669 890

Passcode: EG2uo7X8


Learning Objectives: 

  • Describe the stages of cardiovascular-kidney-metabolic (CKM) syndrome and use the clinical criteria described in the 2026 AHA/ACC/ADA/ASN guideline to classify a patient's CKM syndrome stage based on their risk factors

  • Identify appropriate non-pharmacologic recommendations for patients based on their CKM stage and individual risk factors

  • Recognize when to recommend RAAS inhibitors, GLP-1 based therapies, MRAs, and SGLT-2 inhibitors for patients with overlapping CKM conditions

Session date: 
11/12/2026 - 2:00pm to 3:00pm CST
Location: 
In-person and Virtually
Will be determined by room availability
600 Highland Ave
Madison, WI 53705
United States
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Megan Johnson
Lauren Koch
Mitchell Schumann